Kunming Zhao

1.0k total citations
34 papers, 712 citations indexed

About

Kunming Zhao is a scholar working on Molecular Biology, Cancer Research and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Kunming Zhao has authored 34 papers receiving a total of 712 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 15 papers in Cancer Research and 7 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Kunming Zhao's work include RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (5 papers). Kunming Zhao is often cited by papers focused on RNA modifications and cancer (8 papers), Cancer-related molecular mechanisms research (7 papers) and MicroRNA in disease regulation (5 papers). Kunming Zhao collaborates with scholars based in China, United Kingdom and Australia. Kunming Zhao's co-authors include Ying Hu, Xingwen Wang, Wenjie Ge, Xuting Xue, Huayi Li, Miao Yu, Mengmeng He, Yiwei Cheng, Dianke Yu and Jiao Luo and has published in prestigious journals such as Journal of Biological Chemistry, Environmental Science & Technology and The Science of The Total Environment.

In The Last Decade

Kunming Zhao

34 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kunming Zhao China 15 456 267 74 71 66 34 712
Jianhua Xiong China 14 490 1.1× 232 0.9× 83 1.1× 62 0.9× 90 1.4× 55 861
Qianwen Zhao China 16 406 0.9× 136 0.5× 122 1.6× 112 1.6× 70 1.1× 59 874
Xiaohuan Yuan China 18 331 0.7× 167 0.6× 45 0.6× 46 0.6× 61 0.9× 52 902
Zeyu Yang China 15 322 0.7× 110 0.4× 75 1.0× 91 1.3× 85 1.3× 65 803
Wenli Guo China 18 321 0.7× 207 0.8× 117 1.6× 90 1.3× 32 0.5× 49 953
Yao Tan China 14 359 0.8× 195 0.7× 105 1.4× 107 1.5× 29 0.4× 38 800
Huixiang Li China 18 531 1.2× 303 1.1× 79 1.1× 167 2.4× 46 0.7× 52 932
Haili Huang China 22 588 1.3× 308 1.2× 92 1.2× 101 1.4× 133 2.0× 47 1.0k
Yanlei Yang China 15 395 0.9× 219 0.8× 29 0.4× 72 1.0× 56 0.8× 38 729

Countries citing papers authored by Kunming Zhao

Since Specialization
Citations

This map shows the geographic impact of Kunming Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kunming Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kunming Zhao more than expected).

Fields of papers citing papers by Kunming Zhao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kunming Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kunming Zhao. The network helps show where Kunming Zhao may publish in the future.

Co-authorship network of co-authors of Kunming Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Kunming Zhao. A scholar is included among the top collaborators of Kunming Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kunming Zhao. Kunming Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Tao, et al.. (2025). Histone acetylation activated-IGF2BP3 regulates cyclin D1 mRNA stability to drive cell cycle transition and tumor progression of hepatocellular carcinoma. International Journal of Biological Macromolecules. 306(Pt 3). 141678–141678. 3 indexed citations
2.
Xu, Lin, Wanli Ma, Xiaoyu Huo, et al.. (2024). New insights into the function and mechanisms of piRNA PMLCPIR in promoting PM2.5-induced lung cancer. Journal of Advanced Research. 73. 659–670. 9 indexed citations
3.
Xu, Lin, Yanting Li, Wanli Ma, et al.. (2023). Diesel exhaust particles exposure induces liver dysfunction: Exploring predictive potential of human circulating microRNAs signature relevant to liver injury risk. Journal of Hazardous Materials. 458. 132060–132060. 6 indexed citations
4.
Zhang, Donghui, Xinya Liu, Yuan Qi, et al.. (2023). Binding, activity and risk assessment of bisphenols toward farnesoid X receptor pathway: In vitro and in silico study. The Science of The Total Environment. 869. 161701–161701. 8 indexed citations
5.
6.
Wang, Xingwen, et al.. (2022). Mitochondria-localized lncRNA HITT inhibits fusion by attenuating formation of mitofusin-2 homotypic or heterotypic complexes. Journal of Biological Chemistry. 299(2). 102825–102825. 4 indexed citations
7.
8.
Zhao, Kunming, Xingwen Wang, Dong Zhao, et al.. (2022). lncRNA HITT Inhibits Lactate Production by Repressing PKM2 Oligomerization to Reduce Tumor Growth and Macrophage Polarization. Research. 2022. 9854904–9854904. 35 indexed citations
9.
Zhao, Dong, Shanliang Zheng, Xingwen Wang, et al.. (2022). iASPP is essential for HIF-1α stabilization to promote angiogenesis and glycolysis via attenuating VHL-mediated protein degradation. Oncogene. 41(13). 1944–1958. 11 indexed citations
10.
Xu, Lin, Wanli Ma, Yuan Jin, et al.. (2022). N, N-dimethylformamide exposure induced liver abnormal mitophagy by targeting miR-92a-1-5p-BNIP3L pathway in vivo and vitro. The Science of The Total Environment. 839. 156218–156218. 18 indexed citations
11.
12.
Jin, Yuan, Qianqian Zhang, Yuzhen Liu, et al.. (2022). Identifying microRNAs that drive BaP-induced pulmonary effects: Multiple patterns of mechanisms underlying activation of the toxicity pathways. Environment International. 170. 107588–107588. 8 indexed citations
13.
Luo, Jiao, Yufei Hou, Wanli Ma, et al.. (2021). A novel epigenetic mechanism unravels hsa-miR-148a-3p-mediated CYP2B6 downregulation in alcoholic hepatitis disease. Biochemical Pharmacology. 188. 114582–114582. 15 indexed citations
14.
Xu, Lin, Wendi Chen, Jing Chen, et al.. (2021). PIWI-interacting RNA-23210 protects against acetaminophen-induced liver injury by targeting HNF1A and HNF4A. Biochemical Pharmacology. 197. 114897–114897. 13 indexed citations
15.
Xu, Lin, Qianwen Zhao, Daochuan Li, et al.. (2021). MicroRNA-760 resists ambient PM2.5-induced apoptosis in human bronchial epithelial cells through elevating heme-oxygenase 1 expression. Environmental Pollution. 284. 117213–117213. 13 indexed citations
16.
Li, Huayi, et al.. (2020). A previously identified apoptosis inhibitor iASPP confers resistance to chemotherapeutic drugs by suppressing senescence in cancer cells. Journal of Biological Chemistry. 295(12). 4049–4063. 14 indexed citations
17.
Li, Huayi, Xingwen Wang, Cheng Zhang, et al.. (2018). HDAC1-induced epigenetic silencing of ASPP2 promotes cell motility, tumour growth and drug resistance in renal cell carcinoma. Cancer Letters. 432. 121–131. 15 indexed citations
18.
Zhang, Xunan, Wei Zong, Hongmei Bi, et al.. (2018). Hierarchical drug release of pH-sensitive liposomes encapsulating aqueous two phase system. European Journal of Pharmaceutics and Biopharmaceutics. 127. 177–182. 23 indexed citations
19.
Ge, Wenjie, Kunming Zhao, Xingwen Wang, et al.. (2017). iASPP Is an Antioxidative Factor and Drives Cancer Growth and Drug Resistance by Competing with Nrf2 for Keap1 Binding. Cancer Cell. 32(5). 561–573.e6. 151 indexed citations
20.
Zhao, Kunming, et al.. (2017). EGR-1/ASPP1 inter-regulatory loop promotes apoptosis by inhibiting cyto-protective autophagy. Cell Death and Disease. 8(6). e2869–e2869. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jianhua Xiong Breakdown of academic impact, for papers by Qianwen Zhao Breakdown of academic impact, for papers by Xiaohuan Yuan Breakdown of academic impact, for papers by Zeyu Yang Breakdown of academic impact, for papers by Wenli Guo Breakdown of academic impact, for papers by Yao Tan Breakdown of academic impact, for papers by Huixiang Li Breakdown of academic impact, for papers by Haili Huang Breakdown of academic impact, for papers by Yanlei Yang
Rankless by CCL
2026